Bungarus candidus venom toxins

Bungarus candidus venom toxins comprise a potent mixture of proteins secreted by the Malayan krait, a medically significant elapid snake endemic to Southeast Asia. The venom is primarily neurotoxic, with its composition dominated by two major protein families: three-finger toxins (3FTxs) and phospholipase A2 (PLA2) enzymes. Postsynaptic neurotoxins, such as alpha-bungarotoxin and the reversible blocker candoxin, bind with high affinity to nicotinic acetylcholine receptors at the neuromuscular junction, while presynaptic beta-bungarotoxins disrupt the release of neurotransmitters from nerve terminals. This dual mechanism of action leads to progressive flaccid paralysis, typically manifesting first as ptosis and bulbar palsy, potentially culminating in fatal respiratory failure if untreated. Therapeutic management relies heavily on the timely administration of specific antivenoms, which contain polyclonal antibodies that sequester and neutralize the circulating toxins. Understanding the molecular profile and geographical variation of these toxins is critical for the development of effective diagnostic biosensors and refined antivenom therapies.

Other names

Malayan krait venomBlue krait venom toxinsBungarus candidus neurotoxinsB. candidus venom proteins

Antibody-mediated neutralization of circulating venom proteins through the binding of specific F(ab')2 or IgG fragments, preventing the toxins from interacting with their physiological targets such as nicotinic acetylcholine receptors and presynaptic terminals.